Status:
TERMINATED
COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA)
Lead Sponsor:
Centre Hospitalier Intercommunal Creteil
Conditions:
Covid19
Retina Injury
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this research is to build a collection of non-invasive retinal imaging (OCT and OCTA) in order to investigate the incidence and impact of retinal damage in patients who have or have h...
Detailed Description
This monocentric study is aimed at 3 types of patients: * Those who have been hospitalized for Covid-19 during the epidemic * Newly infected and diagnosed patients Covid-19 * Those with paucisymptoma...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Diagnosis of COVID-19 proven on RT-PCR, antigenic test or chest CT scan
- Affiliation to the general social security system
- A consent signed by the patient
Exclusion
- \- Refusal of patient participation
Key Trial Info
Start Date :
November 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 17 2023
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04881253
Start Date
November 5 2021
End Date
January 17 2023
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Intercommunal de Créteil
Créteil, IDF, France, 94000